Relating to: utilization management controls for antipsychotic prescription drugs under the Medical Assistance program. (FE)

SB 83 creates exceptions to prior authorization requirements for antipsychotic drugs under the state's Medical Assistance program (Medicaid). It specifies four situations where prior approval isn't needed for recipients aged 18+: if the drug was previously approved at a different dose, the recipient was recently enrolled after 30 days of continuous use, prior authorization expired after 60 days of continuous use, or the recipient was stabilized on the drug after a recent hospital discharge. The bill does not override federal Medicaid rules. It directly affects Medicaid recipients prescribed antipsychotic medications who meet these specific criteria.